PPARGC1A and Insulin resistance: In fact, it has been speculated that altered PPARGC1A gene expression might contribute to developing insulin resistance by impaired metabolic pathways related to cardiovascular risk (e.g., PPAR-mediated adipocyte differentiation, lipid oxidation, gluconeogenesis in the liver, or glucose transport in the muscles) (Vohl et al., 2005).